| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.300 | None | 0.929 | 13 | 0 | 1999 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2011 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1998 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 2004 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.020 | None | < 0.001 | 2 | 1 | 2004 | 2007 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2008 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
prolyl endopeptidase | 0.576 | 0.731 | 8.0E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
angiopoietin like 4 | 0.498 | 0.731 | 2.3E-11 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
sortilin 1 | 0.573 | 0.615 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily G member 5 | 0.592 | 0.577 | 3.1E-21 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATP binding cassette subfamily G member 8 | 0.573 | 0.538 | 2.4E-20 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
upstream transcription factor 1 | 0.592 | 0.692 | 2.4E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
very low density lipoprotein receptor | 0.558 | 0.692 | 2.0E-11 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cellular repressor of E1A stimulated genes 1 | 0.663 | 0.423 | 1.2E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
MYD88 innate immune signal transduction adaptor | 0.414 | 0.923 | 0.12 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
chromogranin A | 0.490 | 0.808 | 3.0E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |